Quick, easy access to accurate, up-to-the-minute information on early-stage compounds, their place in the market, and the companies and deals making headway in that particular area can make all the difference when it comes to confidently recommending the best fit for your company.
With Thomson Reuters, you can quickly:
- Understand how your pipeline could be complemented by a potential partners’
- Identify key market, regulatory, science and technology trends and insights that may affect the company’s internal portfolio
- Gauge how heavy generic competition is likely to be and when generic entry is expected
- Consider competitive dosing and PK information